Navigation Menu is only visible when JavaScript is enabled
American Society of Human Genetics - San Diego - October 18-22, 2014 Contact Search
 

Continuing Education Credits (CMEs and CEUs)

Poster Sessions are not eligible for CME or CEU credits

 

For questions, contact ashgmeetings@ashg.org. For printable information on continuing education credits, visit Downloadable Items.

 

Continuing Medical Education Credits (CMEs)

 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Medical Genetics and Genomics and the American Society of Human Genetics. The American College of Medical Genetics and Genomics is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 30.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Procedures: There is a nonrefundable $45 fee payable during the registration process.You can apply for credits through the online application available beginning October 22, 2014. The deadline to submit your request is December 29, 2014. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended. Please see the section below for the learning objectives, target audience, disclosure policy, and a list of presenters' financial disclosures.

MDs and PhDs should apply for CMEs. The American Board of Medical Genetics (ABMG) will accept CMEs for MDs or PhDs participating in the Maintenance of Certification (MOC) program in any ABMG specialty.

 


 

Continuing Education Unit Credits (CEUs) for Genetic Counselors

 

ASHG has been approved for up to 3.25 Category 1 CEU credits (30 contact hours) for genetic counselors through the National Society of Genetic Counselors (NSGC). NSGC is approved as an authorized provider of continuing education and training by the International Association for Continuing Education and Training (IACET).

Procedures: There is a nonrefundable $35 fee payable during the registration process. Registrants MUST apply for credits via the online submission system after
the meeting. The submission site will open on Wednesday, October 22, 2014. The deadline to request credits is Monday, December 1, 2014. No submissions will
be taken after this deadline. You will need your registration ID to complete the CEU application. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended.

Genetic counselors and nurses should apply for CEUs. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of certification and recertification.

 


 

Continuing Education Unit Credits (CEUs) for California-Licensed Clinical and Molecular Laboratory Directors (PACE)

 

ASHG has been approved for Continuing Education Units for up to 30.00 units through the Professional Acknowledgment for Continuing Education (P.A.C.E.) program for California-Licensed Clinical and Molecular Laboratory Directors.

Procedures: There is a nonrefundable $35 fee payable during the registration process. You may also pick up your CEU packet in the ASHG Meeting Office, Room
23. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended. The deadline to submit your request for PACE
credits is Monday, December 1, 2014. No requests will be taken after this date.


Clinical Laboratory Scientists should apply for PACE CEUs. ABMG will accept PACE CEUs for diplomats participating in the MOC program in the following categories: Clinical Biochemical Geneticist, Clinical Cytogeneticist, and Clinical Molecular Geneticist.
 

 


 

ASHG 2014 Learning Objectives

 

All attendees obtaining CME/CEU credits will be able to apply newly acquired knowledge and use of methods in the evaluation, diagnosis, intervention, treatment and follow-up of patients with a variety of disorders. At the completion of the meeting, participants will be able to: (1) describe gaps in knowledge of facts and new methods in genetics; (2) demonstrate ways that the new information and its context may be applied in their own practices; (3) explain interpret results of complex genetic tests and recognize instances of most appropriate use; and (4) understand in detail the benefits and potential harms of using the newest genetic technologies.

  • Identify and fill gaps in knowledge in human genetics in areas of statistical analysis, full genome sequencing, next generation sequencing, genetic neurodegenerative and other disorders, epigenetics, and evolutionary genetics.
  • Explain the value and use of newest technological methods in full genome sequencing in diagnosis of disorders and in family population studies.
  • Provide context from discussions on the benefits and harms of returning results of full genome sequencing to patients.
  • Set principles for the provision of results and their interpretation in full genome sequencing and the diagnosis of genetic risks.
  • Accrue guidelines for the successful counseling of patients receiving complex genetic results.
  • Present the newest results of gene therapy trials so clinicians may enroll patients or apply therapies to appropriate patents.
  • Identify and explain the newest non-invasive prenatal diagnostic methods.
  • Integrate results of genomic testing into electronic health records and other methods to store information.
  • Recognize methods to use centralized databases in the diagnosis and treatment of patients.

 


 

ASHG 2014 Target Audience

 

This meeting is targeted to research scientists, clinical and laboratory practitioners, and others interested in human genetics. The program is varied so that participants may select from several concurrent sessions those that fit their specialized research interests and clinical practice applications.

 

ASHG Annual Meeting attendees include:

 

  • Scientists/Researchers
  • Laboratory geneticists, directors, technicians, and technologists
  • Educators
  • Medical and clinical geneticists
  • Physicians of all specialties with an interest in genetics, genomics, and the genetic basis of disease
  • Genetic counselors
  • Nurses
  • Biotechnology and pharmaceutical development professionals
  • Fellows, trainees, and students

 


 

SPEAKER AND AUTHOR DISCLOSURES/CONFLICT OF INTEREST

 

In accordance with the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American College of Medical Genetics and
Genomics (ACMG) and ASHG, all faculty, speakers, and moderators must disclose the existence of any financial interest and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) to be discussed during their presentation: receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. If a member of the ASHG 2014 Program Committee indicated a relationship that could be perceived by some as a real or apparent conflict of interest in planning the program, the committee member refrained from discussion.

 

Speaker Conflict of Interest: An alphabetical list of committee members involved in the programming of the meeting, as well as invited session speakers and authors of abstracts who have disclosed the existence of significant financial interest or other relationships the presenter has with companies or organizations that may be perceived to bias the presentation is listed below. This information allows the listener/attendee to be fully knowledgeable in evaluating the presentation, and is required to meet CME and CEU requirements. All speakers have a conflict of interest slide automatically inserted into their presentation. For speakers that indicated a conflict, the disclosure information they provided during abstract submission or completion of the online conflict of interest form is used automatically. The presenters listed in the documents at the bottom of this page have indicated a relationship that within the context of their presentation could be perceived by some as a real or apparent conflict of interest, but do not consider that it will influence their presentation. The disclosures have been reviewed and conflicts of interest resolved or managed. The number following each company name represents the specific relationship from the list below.

 

1. Stock options or bond holdings in a for-profit corporation or self-directed pensionplan
2. Research grants, other grants, scholarships, or fellowships
3. Employment (full- or part-time)
4. Ownership or partnership
5. Consulting fees or other remuneration
6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
7. Receipt of royalties
8. Speakers' bureau
9. Receipt of substantial in-kind or donated goods or services
10. Inventor/patent owner

11. Advisor
12. Collaboration
13. Company owner
14. Receipt of travel grants/honoraria
15. Other

 

Committee Members Disclosure Information

 

Invited Speaker and Platform Author Conflicts

 

Invited Speaker and Platform Author No Conflicts

 

Questions: ashgmeetings@ashg.org

 

 

Contact Meeting Management

 

The American Society of Human Genetics, Incorporated | 9650 Rockville Pike, Bethesda, Maryland 20814
society@ashg.org 1-866-HUM-GENE (301) 634-7300
Privacy Policy